Sarcoidosis. A review of diagnosis, clinical features and treatment
DOI:
https://doi.org/10.12775/JEHS.2024.56.007Keywords
sarcoidosis, cardiac sarcoidosis, epidemiology, positron emission tomographyAbstract
Introduction: Sarcoidosis is a progressive chronic multisystemic inflammatory disease of unclear pathogenesis, which presents with noncaseating granulomas and is complicated to diagnose due to the variable clinical presentation of patients. Sarcoidosis may attack any organ, but especially the pulmonary, cutaneous, lymphatic, ocular, hepatic and splenic systems. The most frequent presentations are prolonged cough, rash, visual problems, peripheral lymphadenopathy, tiredness, and occasional abnormality of the chest X-ray. The diagnostic evaluation of sarcoidosis is difficult and often involves a combined effort of clinical data and appropriate imaging modalities.
Purpose: The purpose of this article is to review the available literature on the epidemiology, clinical manifestations and management of patients with sarcoidosis
Materials and method: The available literature in PubMed was reviewed to write the article, using the keywords ,,sarcoidosis”, ,,cardiac sarcoidosis”, ,,pulmonary sarcoidosis” and ,,cutaneous sarcoidosis”.
Conclusion: Sarcoidosis is associated with a significant increase in patient mortality, as well as decreased quality of life and physical disability. Efforts to accurately predict disease progression allow for more comprehensive and personalized patient care. As a life threatening disease, sarcoidosis needs to be diagnosed early and treated appropriately.
References
Sève P, Pacheco Y, Durupt F, Jamilloux Y, Gerfaud-Valentin M, Isaac S, Boussel L, Calender A, Androdias G, Valeyre D, El Jammal T. Sarcoidosis: A Clinical Overview from Symptoms to Diagnosis. Cells. 2021 Mar 31;10(4):766. doi: 10.3390/cells10040766. PMID: 33807303; PMCID: PMC8066110.
Jain R, Yadav D, Puranik N, Guleria R, Jin JO. Sarcoidosis: Causes, Diagnosis, Clinical Features, and Treatments. J Clin Med. 2020 Apr 10;9(4):1081. doi: 10.3390/jcm9041081. PMID: 32290254; PMCID: PMC7230978.
Besnier E.H. Lupus Pernio de La Face; Synovites Fongueuses (Scrofulo-Tuberculeuses) Symétriques Des Extrémités Supérieures. Ann. Derm. Syph. 1889;10:333–336.
Sakthivel P., Bruder D. Mechanism of Granuloma Formation in Sarcoidosis. Curr. Opin. Hematol. 2017;24:59–65. doi: 10.1097/MOH.0000000000000301.
Hunninghake G. Statement on sarcoidosis. Am. J. Respir. Crit. Care Med. 1999;160:736–755.
Baughman R.P., Teirstein A.S., Judson M.A., Rossman M.D., Yeager H., Jr., Bresnitz E.A., DePalo L., Hunninghake G., Iannuzzi M.C., Johns C.J., et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am. J. Respir. Crit. Care Med. 2001;164:1885–1889. doi: 10.1164/ajrccm.164.10.2104046.
Li C.-W., Tao R.-J., Zou D.-F., Li M.-H., Xu X., Cao W.-J. Pulmonary sarcoidosis with and without extrapulmonary involvement: A cross-sectional and observational study in china. BMJ Open. 2018;8:e018865. doi: 10.1136/bmjopen-2017-018865.
Siltzbach L.E., James D.G., Neville E., Turiaf J., Battesti J.P., Sharma O.P., Hosoda Y., Mikami R., Odaka M. Course and prognosis of sarcoidosis around the world. Am. J. Med. 1974;57:847–852. doi: 10.1016/0002-9343(74)90160-0.
Miyara M., Amoura Z., Parizot C., Badoual C., Dorgham K., Trad S., Kambouchner M., Valeyre D., Chapelon-Abric C., Debré P., et al. The immune paradox of sarcoidosis and regulatory t cells. J. Exp. Med. 2006;203:359–370. doi: 10.1084/jem.20050648.
Iannuzzi M.C., Rybicki B.A., Teirstein A.S. Sarcoidosis. N. Engl. J. Med. 2007;357:2153–2165. doi: 10.1056/NEJMra071714.
Prior C., Knight R.A., Herold M., Ott G., Spiteri M.A. Pulmonary sarcoidosis: Patterns of cytokine release in vitro. Eur. Respir. J. 1996;9:47–53. doi: 10.1183/09031936.96.09010047.
Arkema E.V., Cozier Y.C. Epidemiology of Sarcoidosis: Current Findings and Future Directions. Ther. Adv. Chronic Dis. 2018;9:227–240. doi: 10.1177/2040622318790197.
Zissel G. Cellular activation in the immune response of sarcoidosis. Semin. Respir. Crit. Care Med. 2014;35:307–315. doi: 10.1055/s-0034-1376861.
Pereira C.A.C., Dornfeld M.C., Baughman R., Judson M.A. Clinical Phenotypes in Sarcoidosis. Curr. Opin. Pulm. Med. 2014;20:496–502. doi: 10.1097/MCP.0000000000000077.
Valeyre D., Prasse A., Nunes H., Uzunhan Y., Brillet P.-Y., Müller-Quernheim J. Sarcoidosis. Lancet. 2014;383:1155–1167. doi: 10.1016/S0140-6736(13)60680-7.
Nunes H., Bouvry D., Soler P., Valeyre D. Sarcoidosis. Orphanet J. Rare Dis. 2007;2:46. doi: 10.1186/1750-1172-2-46.
Nardi A., Brillet P.-Y., Letoumelin P., Girard F., Brauner M., Uzunhan Y., Naccache J.-M., Valeyre D., Nunes H. Stage IV Sarcoidosis: Comparison of Survival with the General Population and Causes of Death. Eur. Respir. J. 2011;38:1368–1373. doi: 10.1183/09031936.00187410.
Swigris J.J., Olson A.L., Huie T.J., Fernandez-Perez E.R., Solomon J., Sprunger D., Brown K.K. Sarcoidosis-Related Mortality in the United States from 1988 to 2007. Am. J. Respir. Crit. Care Med. 2011;183:1524–1530. doi: 10.1164/rccm.201010-1679OC.
Kirkil G., Lower E.E., Baughman R.P. Predictors of Mortality in Pulmonary Sarcoidosis. Chest. 2018;153:105–113. doi: 10.1016/j.chest.2017.07.008.
Morimoto T., Azuma A., Abe S., Usuki J., Kudoh S., Sugisaki K., Oritsu M., Nukiwa T. Epidemiology of Sarcoidosis in Japan. Eur. Respir. J. 2008;31:372–379. doi: 10.1183/09031936.00075307.
Jamilloux Y., Maucort-Boulch D., Kerever S., Gerfaud-Valentin M., Broussolle C., Eb M., Valeyre D., Seve P. Sarcoidosis-Related Mortality in France: A Multiple-Cause-of-Death Analysis. Eur. Respir. J. 2016;48:1700–1709. doi: 10.1183/13993003.00457-2016.
Peros-Golubicic T., Ljubic S. Cigarette smoking and sarcoidosis. Acta Med. Croat. 1995;49:187–193.
Siltzbach L.E. Current thoughts on the epidemiology and etiology of sarcoidosis. Am. J. Med. 1965;39:361–368. doi: 10.1016/0002-9343(65)90205-6.
Arkema E.V., Cozier Y.C. Epidemiology of sarcoidosis: Current findings and future directions. Ther. Adv. Chronic Dis. 2018;9:227–240. doi: 10.1177/2040622318790197.
Martusewicz-Boros M.M., Boros P.W., Wiatr E., Roszkowski-Śliż K. What comorbidities accompany sarcoidosis? A large cohort (n = 1779) patients analysis. Sarcoidosis Vasc. Diffus. Lung Dis. 2015;32:115–120.
Nowinski A., Puscinska E., Goljan-Geremek A., Bednarek M., Kaminski D., Gorecka D. Comorbidities associated with sarcoidosis—Results from long-term observational study. Eur. Respir. J. 2014;44:461.
Wu C.H., Chung P.I., Wu C.Y., Chen Y.T., Chiu Y.W., Chang Y.T., Liu H.N. Comorbid autoimmune diseases in patients with sarcoidosis: A nationwide case-control study in taiwan. J. Dermatol. 2017;44:423–430. doi: 10.1111/1346-8138.13654.
Carmi O., Berla M., Edelstein E., Levy Y. Coexisting systemic sclerosis-polymyositis and sarcoidosis: Case report and review of the literature. J. Clin. Rheumatol. Pract. Rep. Rheum. Musculoskelet. Dis. 2018;24:238–240. doi: 10.1097/RHU.0000000000000699.
Grunewald J., Spagnolo P., Wahlstrom J., Eklund A. Immunogenetics of disease-causing inflammation in sarcoidosis. Clin. Rev. Allergy Immunol. 2015;49:19–35. doi: 10.1007/s12016-015-8477-8
Fischer A., Ellinghaus D., Nutsua M., Hofmann S., Montgomery C.G., Iannuzzi M.C., Rybicki B.A., Petrek M., Mrazek F., Pabst S., et al. Identification of immune-relevant factors conferring sarcoidosis genetic risk. Am. J. Respir. Crit. Care Med. 2015;192:727–736. doi: 10.1164/rccm.201503-0418OC.
Kucera G.P., Rybicki B.A., Kirkey K.L., Coon S.W., Major M.L., Maliarik M.J., Iannuzzi M.C. Occupational risk factors for sarcoidosis in african-american siblings. Chest. 2003;123:1527–1535. doi: 10.1378/chest.123.5.1527.
Newman L.S., Rose C.S., Bresnitz E.A., Rossman M.D., Barnard J., Frederick M., Terrin M.L., Weinberger S.E., Moller D.R., McLennan G., et al. A case control etiologic study of sarcoidosis: Environmental and occupational risk factors. Am. J. Respir. Crit. Care Med. 2004;170:1324–1330. doi: 10.1164/rccm.200402-249OC.
Vihlborg P., Bryngelsson L., Andersson L., Graff P. Risk of sarcoidosis and seropositive rheumatoid arthritis from occupational silica exposure in swedish iron foundries: A retrospective cohort study. BMJ Open. 2017;7:e016839. doi: 10.1136/bmjopen-2017-016839.
Izbicki G., Chavko R., Banauch G.I., Weiden M.D., Berger K.I., Aldrich T.K., Hall C., Kelly K.J., Prezant D.J. World trade center “sarcoid-like” granulomatous pulmonary disease in new york city fire department rescue workers. Chest. 2007;131:1414–1423. doi: 10.1378/chest.06-2114.
Newman L. Aetiologies of sarcoidosis. Eur. Respir. Monogr. 2005;32:23–48.
Vidal S., De la Horra C., Martin J., Montes-Cano M., Rodríguez E., Respaldiza N., Rodriguez F., Varela J., Medrano F., Calderón E. Pneumocystis jirovecii colonisation in patients with interstitial lung disease. Clin. Microbiol. Infect. 2006;12:231–235. doi: 10.1111/j.1469-0691.2005.01337.x.
Hirano A., Kataoka M., Nakata Y., Takeda K., Kamao T., Hiramatsu J., Kimura G., Tanimoto Y., Kanehiro A., Tanimoto M. Sarcoidosis occurring after interferon-alpha therapy for chronic hepatitis c: Report of two cases. Respirology. 2005;10:529–534. doi: 10.1111/j.1440-1843.2005.00745.x.
Trien R., Cooper C.J., Paez D., Colon E., Ajmal S., Salameh H. Interferon-alpha-induced sarcoidosis in a patient being treated for hepatitis c. Am. J. Case Rep. 2014;15:235–238.
Brjalin V., Salupere R., Tefanova V., Prikk K., Lapidus N., Jõeste E. Sarcoidosis and chronic hepatitis c: A case report. World J. Gastroenterol. 2012;18:5816–5820. doi: 10.3748/wjg.v18.i40.5816.
Ramos-Casals M., Mana J., Nardi N., Brito-Zeron P., Xaubet A., Sanchez-Tapias J.M., Cervera R., Font J. Sarcoidosis in patients with chronic hepatitis c virus infection: Analysis of 68 cases. Medicine. 2005;84:69–80. doi: 10.1097/01.md.0000157577.69729.e6.
Kaiser Y., Eklund A., Grunewald J. Moving target: Shifting the focus to pulmonary sarcoidosis as an autoimmune spectrum disorder. Eur. Respir. J. 2019;54:1802153. doi: 10.1183/13993003.021532018.
Grunewald J., Kaiser Y., Ostadkarampour M., Rivera N.V., Vezzi F., Lötstedt B., Olsen R.-A., Sylwan L., Lundin S., Käller M. T-cell receptor—Hla-drb1 associations suggest specific antigens in pulmonary sarcoidosis. Eur. Respir. J. 2016;47:898–909. doi: 10.1183/13993003.01209-2015.
Lynch JP, 3rd, Hwang J, Bradfield J, Fishbein M, Shivkumar K, Tung R. Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment. Semin Respir Crit Care Med. 2014;35:372–390.
Koyama T, Ueda H, Togashi K, Umeoka S, Kataoka M, Nagai S. Radiologic manifestations of sarcoidosis in various organs. Radiographics. 2004;24:87–104.
Costabel U, Bonella F, Ohshimo S, Guzman J. Diagnostic modalities in sarcoidosis: BAL, EBUS, and PET. Semin Respir Crit Care Med. 2010;31:404–408.
Pierce T.B., Margolis M., Razzuk M.A. Sarcoidosis: Still a mystery? Bayl. Univ. Med Cent. Proc. 2001;14:8–12. doi: 10.1080/08998280.2001.11927724.
Hu X., Carmona E.M., Yi E.S., Pellikka P.A., Ryu J. Causes of death in patients with chronic sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 2016;33:275–280.
Wirnsberger R.M., de Vries J., Wouters E.F., Drent M. Clinical presentation of sarcoidosis in the netherlands an epidemiological study. Neth. J. Med. 1998;53:53–60. doi: 10.1016/S0300-2977(98)00058-8.
Judson M.A., Baughman R.P., Costabel U., Mack M., Barnathan E.S. The potential additional benefit of infliximab in patients with chronic pulmonary sarcoidosis already receiving corticosteroids: A retrospective analysis from a randomized clinical trial. Respir. Med. 2014;108:189–194. doi: 10.1016/j.rmed.2013.11.019.
Pande A., Culver D.A. Knowing when to use steroids, immunosuppressants or biologics for the treatment of sarcoidosis. Expert Rev. Respir. Med. 2020;14:285–298. doi: 10.1080/17476348.2020.1707672.
James W.E., Judson M.A. Therapeutic strategies for pulmonary sarcoidosis. Expert Rev. Respir. Med. 2020;14:391–403. doi: 10.1080/17476348.2020.1721284.
Gibson G., Prescott R., Muers M., Middleton W., Mitchell D., Connolly C., Harrison B. British thoracic society sarcoidosis study: Effects of long term corticosteroid treatment. Thorax. 1996;51:238–247. doi: 10.1136/thx.51.3.238.
Grunewald J., Grutters J.C., Arkema E.V., Saketkoo L.A., Moller D.R., Müller-Quernheim J. Sarcoidosis. Nat. Rev. Dis. Primers. 2019;5:45. doi: 10.1038/s41572-019-0096-x.
Muller-Quernheim J., Kienast K., Held M., Pfeifer S., Costabel U. Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen. Eur. Respir. J. 1999;14:1117–1122. doi: 10.1183/09031936.99.14511179.
Baughman R., Winget D., Lower E. Methotrexate is steroid sparing in acute sarcoidosis: Results of a double blind, randomized trial. Sarcoidosis Vasc. Diffus. Lung Dis. Off. J. WASOG. 2000;17:60–66.
Brill A.-K., Ott S.R., Geiser T. Effect and safety of mycophenolate mofetil in chronic pulmonary sarcoidosis: A retrospective study. Respiration. 2013;86:376–383. doi: 10.1159/000345596.
Korsten P., Mirsaeidi M., Sweiss N.J. Nonsteroidal therapy of sarcoidosis. Curr. Opin. Pulm. Med. 2013;19:516. doi: 10.1097/MCP.0b013e3283642ad0
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Aleksandra Madej, Hanna Senat, Patrycja Grabowska, Patrycja Bolla, Aleksandra Senat, Zuzanna Marczyńska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 253
Number of citations: 0